Animalcare confirms positive full-year results for 2010/11

Animalcare has published its finalised full-year financial results for the 12 months ending on June 30th 2011, a period marked by strong growth for the company.

The recent disposal of the organisation's livestock businesses has allowed the company to increase its focus on its core companion animal operations, thus helping it to achieve above-market growth levels.

Revenue from continuing operations rose by 5.4 percent year on year to 11.8 million pounds, while underlying profit, earnings and cash balance levels also saw increases.

Key product launches conducted during the period included the introduction of the new analgesia and anaesthesia products Sedastart and Sedastop.

The firm expects to achieve further success in the coming months, thanks to the release of four new generic veterinary products and a strong pipeline, as well as the reorganisation of its UK sales force.

James Lambert, chairman of Animalcare, said the board "believes that we will continue to grow the business markedly faster than the market overall and increase our market share".